Useful links
Preventing FNAIT

The drug that we aim to develop for prevention of FNAIT will work in the exact same way as anti-D immuno globulin which today issused to protect Rhesus-negative women from being immunized against RhD antigen on the surface of red blood cells from their foetuses.


The extensive use of anti-D immunoglobulin therapy has shown that immunoglobulins may effectively prevent a woman from being immunized by an antigen from her foetus. Most importantly, the therapy is very safe.